BOULDER, Colo.--(BUSINESS WIRE)--Jan. 26, 2009--Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for
the second quarter of fiscal 2009 on Monday, February 2, 2009, and will
hold a conference call on Tuesday, February 3, 2009 at 9:00 a.m. eastern
time to discuss these results. Robert E. Conway, Chief Executive
Officer, and Michael Carruthers, Chief Financial Officer, will lead the
Conference Call Information
Date: Tuesday, February 3, 2009
Time: 9:00 a.m. eastern time
Pass Code: 2036041
Web Cast: www.arraybiopharma.com
A replay of the call will be available as a webcast on www.arraybiopharma.com
and by phone for one week by dialing toll-free (888) 203-1112 or (719)
457-0820. The access code is 2036041.
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule
drugs to treat patients afflicted with cancer, inflammatory and
metabolic diseases. Our proprietary drug development pipeline includes
clinical candidates that are designed to regulate therapeutically
important target proteins and are aimed at large market opportunities.
In addition, leading pharmaceutical and biotechnology companies
collaborate with Array to discover and develop drug candidates across a
broad range of therapeutic areas. For more information on Array, please
go to www.arraybiopharma.com.
Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
Source: Array BioPharma Inc.